Identification of Novel Markers of Human Lung Disease
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- The development of novel therapeutics for interstial lung disease
研究概览
简要总结
The purpose of this study is to investigate new therapies for advanced lung disease.
详细描述
This research study is being conducted to learn about the progression and cause of lung disease. By agreeing to be a part of this study, you will allow the lung tissue which would normally have been discarded after your procedure, to be used for research purposes to allow us to understand more about your condition which may potentially lead to novel treatments and therapeutics. For this study, the investigators will isolate specific cells from the lung tissue and measure cellular, molecular and genetic mechanisms responsible for regulating lung disease. No other type of research will be performed on these samples nor will the samples be given to other investigators for unrelated research.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •any one on lung transplant list
排除标准
- •HIV positive
结局指标
主要结局
The development of novel therapeutics for interstial lung disease
时间窗: 10 years
Our research on these human lung cells will provide critical data which will aid in the diagnosis and treatment of a variety of different lung diseases, which have no cure.
次要结局
未报告次要终点
研究者
Megan Ballinger
Research Asst Professor
Ohio State University
